Distinct iPS cells show different cardiac differentiation efficiency

Yohei Ohno, Shinsuke Yuasa, Toru Egashira, Tomohisa Seki, Hisayuki Hashimoto, Shugo Tohyama, Yuki Saito, Akira Kunitomi, Kenichiro Shimoji, Takeshi Onizuka, Toshimi Kageyama, Kojiro Yae, Tomofumi Tanaka, Ruri Kaneda, Fumiyuki Hattori, Mitsushige Murata, Kensuke Kimura, Keiichi Fukuda

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Patient-specific induced pluripotent stem (iPS) cells can be generated by introducing transcription factors that are highly expressed in embryonic stem (ES) cells into somatic cells. This opens up new possibilities for cell transplantation-based regenerative medicine by overcoming the ethical issues and immunological problems associated with ES cells. Despite the development of various methods for the generation of iPS cells that have resulted in increased efficiency, safety, and general versatility, it remains unknown which types of iPS cells are suitable for clinical use. Therefore, the aims of the present study were to assess (1) the differentiation potential, time course, and efficiency of different types of iPS cell lines to differentiate into cardiomyocytes in vitro and (2) the properties of the iPS cell-derived cardiomyocytes. We found that high-quality iPS cells exhibited better cardiomyocyte differentiation in terms of the time course and efficiency of differentiation than low-quality iPS cells, which hardly ever differentiated into cardiomyocytes. Because of the different properties of the various iPS cell lines such as cardiac differentiation efficiency and potential safety hazards, newly established iPS cell lines must be characterized prior to their use in cardiac regenerative medicine.

Original languageEnglish
Article number659739
JournalStem Cells International
DOIs
Publication statusPublished - 2013

Fingerprint

Induced Pluripotent Stem Cells
Cardiac Myocytes
Regenerative Medicine
Embryonic Stem Cells
Cell Line
Safety
Cell Transplantation
Ethics
Transcription Factors

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Distinct iPS cells show different cardiac differentiation efficiency. / Ohno, Yohei; Yuasa, Shinsuke; Egashira, Toru; Seki, Tomohisa; Hashimoto, Hisayuki; Tohyama, Shugo; Saito, Yuki; Kunitomi, Akira; Shimoji, Kenichiro; Onizuka, Takeshi; Kageyama, Toshimi; Yae, Kojiro; Tanaka, Tomofumi; Kaneda, Ruri; Hattori, Fumiyuki; Murata, Mitsushige; Kimura, Kensuke; Fukuda, Keiichi.

In: Stem Cells International, 2013.

Research output: Contribution to journalArticle

Ohno, Y, Yuasa, S, Egashira, T, Seki, T, Hashimoto, H, Tohyama, S, Saito, Y, Kunitomi, A, Shimoji, K, Onizuka, T, Kageyama, T, Yae, K, Tanaka, T, Kaneda, R, Hattori, F, Murata, M, Kimura, K & Fukuda, K 2013, 'Distinct iPS cells show different cardiac differentiation efficiency', Stem Cells International. https://doi.org/10.1155/2013/659739
Ohno, Yohei ; Yuasa, Shinsuke ; Egashira, Toru ; Seki, Tomohisa ; Hashimoto, Hisayuki ; Tohyama, Shugo ; Saito, Yuki ; Kunitomi, Akira ; Shimoji, Kenichiro ; Onizuka, Takeshi ; Kageyama, Toshimi ; Yae, Kojiro ; Tanaka, Tomofumi ; Kaneda, Ruri ; Hattori, Fumiyuki ; Murata, Mitsushige ; Kimura, Kensuke ; Fukuda, Keiichi. / Distinct iPS cells show different cardiac differentiation efficiency. In: Stem Cells International. 2013.
@article{20ec5ed8082a48e9ba504b8d3ce2cff3,
title = "Distinct iPS cells show different cardiac differentiation efficiency",
abstract = "Patient-specific induced pluripotent stem (iPS) cells can be generated by introducing transcription factors that are highly expressed in embryonic stem (ES) cells into somatic cells. This opens up new possibilities for cell transplantation-based regenerative medicine by overcoming the ethical issues and immunological problems associated with ES cells. Despite the development of various methods for the generation of iPS cells that have resulted in increased efficiency, safety, and general versatility, it remains unknown which types of iPS cells are suitable for clinical use. Therefore, the aims of the present study were to assess (1) the differentiation potential, time course, and efficiency of different types of iPS cell lines to differentiate into cardiomyocytes in vitro and (2) the properties of the iPS cell-derived cardiomyocytes. We found that high-quality iPS cells exhibited better cardiomyocyte differentiation in terms of the time course and efficiency of differentiation than low-quality iPS cells, which hardly ever differentiated into cardiomyocytes. Because of the different properties of the various iPS cell lines such as cardiac differentiation efficiency and potential safety hazards, newly established iPS cell lines must be characterized prior to their use in cardiac regenerative medicine.",
author = "Yohei Ohno and Shinsuke Yuasa and Toru Egashira and Tomohisa Seki and Hisayuki Hashimoto and Shugo Tohyama and Yuki Saito and Akira Kunitomi and Kenichiro Shimoji and Takeshi Onizuka and Toshimi Kageyama and Kojiro Yae and Tomofumi Tanaka and Ruri Kaneda and Fumiyuki Hattori and Mitsushige Murata and Kensuke Kimura and Keiichi Fukuda",
year = "2013",
doi = "10.1155/2013/659739",
language = "English",
journal = "Stem Cells International",
issn = "1687-9678",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Distinct iPS cells show different cardiac differentiation efficiency

AU - Ohno, Yohei

AU - Yuasa, Shinsuke

AU - Egashira, Toru

AU - Seki, Tomohisa

AU - Hashimoto, Hisayuki

AU - Tohyama, Shugo

AU - Saito, Yuki

AU - Kunitomi, Akira

AU - Shimoji, Kenichiro

AU - Onizuka, Takeshi

AU - Kageyama, Toshimi

AU - Yae, Kojiro

AU - Tanaka, Tomofumi

AU - Kaneda, Ruri

AU - Hattori, Fumiyuki

AU - Murata, Mitsushige

AU - Kimura, Kensuke

AU - Fukuda, Keiichi

PY - 2013

Y1 - 2013

N2 - Patient-specific induced pluripotent stem (iPS) cells can be generated by introducing transcription factors that are highly expressed in embryonic stem (ES) cells into somatic cells. This opens up new possibilities for cell transplantation-based regenerative medicine by overcoming the ethical issues and immunological problems associated with ES cells. Despite the development of various methods for the generation of iPS cells that have resulted in increased efficiency, safety, and general versatility, it remains unknown which types of iPS cells are suitable for clinical use. Therefore, the aims of the present study were to assess (1) the differentiation potential, time course, and efficiency of different types of iPS cell lines to differentiate into cardiomyocytes in vitro and (2) the properties of the iPS cell-derived cardiomyocytes. We found that high-quality iPS cells exhibited better cardiomyocyte differentiation in terms of the time course and efficiency of differentiation than low-quality iPS cells, which hardly ever differentiated into cardiomyocytes. Because of the different properties of the various iPS cell lines such as cardiac differentiation efficiency and potential safety hazards, newly established iPS cell lines must be characterized prior to their use in cardiac regenerative medicine.

AB - Patient-specific induced pluripotent stem (iPS) cells can be generated by introducing transcription factors that are highly expressed in embryonic stem (ES) cells into somatic cells. This opens up new possibilities for cell transplantation-based regenerative medicine by overcoming the ethical issues and immunological problems associated with ES cells. Despite the development of various methods for the generation of iPS cells that have resulted in increased efficiency, safety, and general versatility, it remains unknown which types of iPS cells are suitable for clinical use. Therefore, the aims of the present study were to assess (1) the differentiation potential, time course, and efficiency of different types of iPS cell lines to differentiate into cardiomyocytes in vitro and (2) the properties of the iPS cell-derived cardiomyocytes. We found that high-quality iPS cells exhibited better cardiomyocyte differentiation in terms of the time course and efficiency of differentiation than low-quality iPS cells, which hardly ever differentiated into cardiomyocytes. Because of the different properties of the various iPS cell lines such as cardiac differentiation efficiency and potential safety hazards, newly established iPS cell lines must be characterized prior to their use in cardiac regenerative medicine.

UR - http://www.scopus.com/inward/record.url?scp=84888869632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888869632&partnerID=8YFLogxK

U2 - 10.1155/2013/659739

DO - 10.1155/2013/659739

M3 - Article

AN - SCOPUS:84888869632

JO - Stem Cells International

JF - Stem Cells International

SN - 1687-9678

M1 - 659739

ER -